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Purpose: The aim of the present study was to evaluate the effect of microfracture and intraarticular autologous
conditioned plasma (ACP) injection on cartilage regeneration in a focal full-thickness chondral defect model created
in the knee joint.
Methods: Full-thickness chondral defects of 3 × 6 mm2 were surgically created in right medial femoral condyles
(MFC) of New Zealand rabbits, and the rabbits were then divided into three groups according to treatment: Group
1 received only microfracture (mfx), Group 2 received mfx plus intraarticular ACP, and Group 3 received mfx; the
defect was covered by the periosteum, and then, ACP was applied subperiosteally and intraarticularly. Twelve
weeks after injection, the animals were sacrificed and the femoral condyles were evaluated macroscopically and
histologically by hematoxylin-eosin staining. Then, histological sections were scored using the International Cartilage
Repair Society (ICRS) visual histological scale.
Results: Findings showed that in both mfx/ACP-treated groups, the defects were filled regularly and smoothly, the
defects had a greater fill and good integration into the surrounding host tissue, and the repair matrix had more
hyaline-like character. On the other hand, defects were filled with an irregular, fibrous cartilage in the mfx-treated
group. Histological scores in Group 2 and Group 3 were better compared to Group 1.
Conclusion: In the present study, we were able to demonstrate a beneficial effect of intraarticular administration of
ACP as a coadjuvant of microfractures in order to regenerate hyaline-like cartilage in full-thickness chondral lesions
in a rabbit model.
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It has been well established that articular cartilage has
poor intrinsic capacity for self-repair due to the low cel-
lular mitotic activity of chondrocytes and its avascularity
[1]. Although many treatment options are currently avail-
able, such as microfracture, osteochondral grafting, and
autologous chondrocyte implants, none of these options* Correspondence: emreergen99@hotmail.com
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hyaline repair tissue that completely fills the defect and
integrates well with the surrounding normal cartilage [2,
3]. The microfracture technique is currently a common
first-line treatment for patients with cartilage defects of
the knee, resulting in the formation of a fibrocartilagi-
nous repair tissue with inferior biomechanical properties
compared to normal hyaline cartilage [4–6]. Therefore,
research is continually being conducted in an attempt to
find biological adjuvant treatments to improve the quality
of the microfracture repair tissue, with the goal ofss article distributed under the terms of the Creative Commons Attribution
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long-term functional improvement [7–13]. The original
concept for clinical application of platelet-rich plasma
(PRP) focused only on the concentration of platelets be-
cause platelets are a natural reservoir of many growth
factors important for tissue healing. More recently, it is
accepted that PRP, like all of the blood-derived biologics
discussed herein, is a milieu of bioactive factors. Broadly,
PRP preparations can be defined as buffy coat or plasma
based. Autologous conditioned plasma (ACP) is a form
of PRP that belongs in the plasma-based group. ACP,
which is an autologous blood product produced by the
centrifugation of whole blood, thereby yielding 2–8 times
higher than baseline concentration of platelets, has pro-
duced various effects on sports injuries and cartilage
[14–27]. The advantages of the use of ACP as an adju-
vant to microfracture are the sealant properties for the
implant, the capacity to promote cellular implantation,
and the presence of growth factors that are involved in
mesenchymal stem cells (MSC) chondrogenic differenti-
ation [28].
The aim of the present study was to investigate the
effect of intraarticular ACP injection, and intraarticular
and subperiosteal ACP injections into the defect cov-
ered by periosteum on cartilage repair, and compare
the results with the results of microfracture alone.Materials and methods
In this study, “Principles of laboratory animal care” (NIH
publication No. 86–23, revised 1985) were followed. The
research protocol was reviewed and approved by the
Ethics Committee of the Experimental Animals of
Faculty of Medicine in Inonu University. The study was
carried out in the facilities of Orthopedics and Trauma-
tology, Pathology and Experimental Animal Production
and Research Center. Rabbits were obtained from
Inonu University Experimental Animal Production and
Research Center. Twenty-one mature (18 weeks old)
New Zealand-type white rabbits, with a mean weight of
2450 g (1950–2900 g) were used in this study. Rabbits
were divided into three groups of seven animals per
group. One hour prior to the surgery, 75 mg/kg of
cefazolin sodium (Sefazol®, Mustafa Nevzat, Turkey)
was administered to all rabbits. All procedures were
carried out under aseptic conditions, using intramuscu-
lar anesthesia with ketamine 35 mg/kg (Ketalar®, Pfizer,
USA), xylazine 5 mg/kg (Rompun®, Bayer, Germany),
and acepromazine 1 mg/kg (Plegicil®, Sanofi, Turkey),
enrofloxacin 10 mg/kg (Baytril-K®, Bayer, Germany),
and tramadol 4 mg/kg (Contramal®, Abdi Ibrahım,
Turkey) were administered to all animals preoperatively
and up to 2 days after surgery.Preparation of autologous-conditioned plasma
Prior to blood drawing, 1 ml of ACD-A (Anticoagulant
Citrate Dextrose Solution; NoClot 400, Cytosol Labora-
tories, Inc.) was drawn into the outer syringe of the ACP
Double syringe system (Arthrex Inc., FL 34108 USA).
Then, 9 ml of venous blood was drawn from the poster-
ior auricular vein, and blood samples were centrifuged
at 1500 rpm for 5 min (Hettich Rotofix 32A). Approxi-
mately 2 ml of thrombocyte-rich plasma (ACP) obtained
from erythrocytes and leukocytes were drawn into the
inner syringe. According to the manufacturer’s reference,
this procedure results in a 3-fold increase in thrombo-
cyte count and a 2- to 6-fold increase in growth factor
levels [25].Surgical procedure
The lower extremities of the animals were prepared ap-
propriately and then covered. After crossing the cuta-
neous and subcutaneous fascia along the right knee
midline using a longitudinal incision, the knee joint was
approached by dislocating patella laterally with using
parapatellar medial arthrotomy. A 3 × 6-mm-wide full-
thickness chondral defect was created in the load-
bearing region of the medial femoral condyle by using a
hand perforator (Aesculap®) and a 2.7-mm-long drill
cap according to the method described by Hui et al.
[29]. After creation of the cartilage defect, each speci-
men then underwent microfracture using a 0.032-in
(0.8 mm) fine wire. Animals were divided into three
groups. In Group 1, microfracture holes penetrating the
subchondral bone plate were created in the periphery
of the defect first and then into the center of the defect
as described previously, leaving 1- to 2-mm bone brid-
ges between the holes. In Group 2, the osteochondral
defect was created similarly to Group 1, and microfrac-
ture was applied. Then, 2 cc of ACP was injected
intraarticularly. In Group 3, an osteochondral defect
was created and microfracture applied before defects
were closed by suturing a 5 × 5-mm periosteum ob-
tained from the anteromedial tibia onto the defect.
Fibrin glue (Beriplast-p®, FarmaTek, Turkey) was used
to ensure that periosteum covered the defect tightly.
Then, 2 cc of ACP was administered under the perios-
teum and intraarticularly. The patella was reduced in
all groups after the completion of the procedures. The
arthrotomies were then closed in layers with a 4.0 vicryl
suture in the deep layer and 3.0 nylon to the skin. After
surgery, the animals were kept in individual cages
(40 cm × 40 cm × 60 cm) at constant temperature and
humidity, with 12:12-h light–dark cycle and unre-
stricted access to a standard diet and water. Animals
were allowed to walk freely with full weight bearing
and without immobilization. For the first 24 h after
















IV. Cell population viability
Predominantly viable 3
Partially viable 1




Bone necrosis/granulation tissue 1
Detached/fracture/callus at base 0
VI. Cartilage mineralization (calcified cartilage)
Normal 3
Abnormal/inappropriate location 0
Fig. 1 Group 1 (microfractures): surface of defect(arrow) showed
surface irregularities
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tered intramuscularly in three doses.
No complications were observed. At 12 weeks post-
intervention, the rabbits were killed using an intravenous
overdose of pentobarbital and the right condyles were
dissected and subjected to macroscopic and microscopic
analyses. For histological analysis, condyles were fixed in
formalin, decalcified in nitric acid, and embedded in par-
affin. Ten-micrometer-thick sagittal cross sections were
cut through the tissue, and sections were stained with
hematoxylin and eosin. The samples were evaluatedTable 2 The results of the comparison with the Conover post hoc t
Groups Surface Matrix Cell distribution
Group 1–2 P < 0.05 P > 0.05 P < 0.05
Group 1–3 P < 0.05 P < 0.05 P < 0.05
Group 2–3 P < 0.05 P < 0.05 P > 0.05independently by two pathologists and graded according
to the International Cartilage Repair Society (ICRS)
histological assessment of cartilage repair [30]. The scale
was comprised of six categories, which assigned scores
to the most prominent feature on each sample. The
highest score (3) was assigned to the ideal repair result
(i.e., truly regenerated tissue), and the lowest score (0)
was assigned to the poorest repair result (Table 1).Statistical analysis
SPSS for Windows version 13.0 and Medcalc version
12.3.0 statistical softwares were used to analyze the histo-
pathological differences between the groups and for data
evaluation. Descriptive criteria for quantitative variables
were presented as median (min–max). Kruskal–Wallis
variance analysis and Conover post hoc test were used to
compare the parameters between the groups (Table 2).
P < 0.05 was considered statistically significant.Ethics
This study has been approved by the appropriate ethics
committee and has therefore been performed in accordance
with ethical standards laid down in the 1964 Declaration of
Helsinki and its later amendments.est in pairs
Cell viability Subchondral bone Calcified cartilage
P < 0.05 P < 0.05 P > 0.05
P < 0.05 P < 0.05 P < 0.05
P > 0.05 P < 0.05 P > 0.05
Fig. 2 Group 2 (microfractures + ACP): repaired tissue (arrow) shows
good integration with healthy surrounding cartilage
Fig. 4 In the mfx-treated group (Group 1), all of the samples presented
an irregular cartilage surface (arrow), a surface with a fibrocartilage matrix,
and predominantly disorganized cell distribution (asterisks) (H&E)
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Macroscopic findings
At the end of the study, macroscopic observation
showed surface irregularities, with a purple-whitish ap-
pearance only in Group 1 (Fig. 1), which was treated
with only microfracture (mfx). Macroscopic observation
of the defect surface in ACP-treated Group 2 (Fig. 2)
and Group 3 (Fig. 3) showed greater regularity, smooth
surfaces, and a surface color similar to the surrounding
cartilage.Fig. 3 Group 3 (microfracture + periost + ACP): repaired tissue
covers almost completely the defect(arrow), greater regularity,
smooth surfaces, and a surface color similar to the
surrounding cartilageHistological findings
In the mfx-treated group (group 1), all of the samples
presented an irregular cartilage surface, a surface with a
fibrocartilage matrix, and predominantly disorganized
cell distribution (Fig. 4). The mfx/ACP-treated group
(Group 2) showed mainly a more regular surface, hyaline
matrix mixed with fibrocartilage, and differences in cell
distribution criteria, ranging from samples with a disor-
ganized cell distribution to others with mixed columnar
to cluster distribution (Fig. 5). In Group 3, the tissue
surface was regular, with a hyaline matrix mixed with
fibrocartilage in some areas but with chondrocytes more
organized in the tissue compared to the mfx/ACP-
treated group (Fig. 6). Cartilage mineralization was un-
altered in all groups. When compared with both mfx/
ACP-treated groups, the mfx group showed a significant
reduction in scores in all categories (Table 3, P < 0.05).
No difference was found in the interobserver histological
grading.Fig. 5 In the mfx plus intraarticular ACP treated group (Group 2),
there are more regular surface (arrows), hyaline matrix mixed with
fibrocartilage, in cell distribution criteria, disorganized cell
distribution (asterisks) (H&E)
Fig. 6 In the Group 3, after mfx, the defect was covered by the
periosteum, and then, ACP was applied subperiosteally and
intraarticularly. The tissue surface was mostly regular (arrows), with a
hyaline matrix mixed with fibrocartilage in some areas but with
chondrocytes more organized (asterisks) (H&E)
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In the present study, we found that ACP injection
intraarticularly or both intraarticularly and subperioste-
ally into a defect covered by periosteum may enhance
cartilage repair in the treatment with microfracture of
focal full-thickness chondral defect in the knee.
Microfracture is the most well-studied marrow-
stimulation procedure and involves the arthroscopic
penetration of the subchondral plate with an awl. The
creation of channels in the subchondral plate allows
for the influx of blood, blood-derived cells, and bone
marrow-derived mesenchymal stem and progenitor cells
(MSCs) into the defect, forming a blood clot populated
with platelets, growth factors, and bone marrow-
derived pluripotent stem cells to allow for the remodel-
ing of the fibrin clot in the defect into fibrocartilage
repair tissue [4–9]. Although microfractures provide
good short-term outcomes for many patients, mid- to
long-term studies have demonstrated gradual decreases
in functional outcomes after 24 to 36 months, poten-
tially due to tissue degradation overtime [4, 5, 11, 13].
This could be explained because of the less durable
fibrocartilage produced after microfracture and theTable 3 Mean ICRS scores of groups
Groups Surface Matrix Cell distribut
Median (min–max) Median (min–max) Median (min
Group 1 (n = 7) 0.0000 (0–0) 1.7143 (1–2) 1.8571 (1–2)
Group 2 (n = 7) 1.7143 (0–3) 2.2857 (2–3) 2.5714 (2–3)
Group 3 (n = 7) 3.0000 (3–3) 2.8571 (2–3) 2.8571 (2–3)
P (Kruskal Wallis) 0.0012 0.0034 0.0049poor integration of this tissue with the native cartilage.
This fact is also consistent with the results of the
current study, since in the mfx treated group, the newly
formed tissue that filled the defect was fibrocartilage.
Therefore, methods for the advancement of the micro-
fracture technique are demanded that may enhance the
content of key matrix components and improve the car-
tilaginous repair tissue such as scaffold enhancement, hya-
luronic acid viscosupplementation, cytokine modulation
techniques, and PRP injections [7–13].
The simple rationale supporting the use of PRP to
treat cartilage injuries lies in the concept that PRP pro-
vides a milieu of bioactive growth factors such as trans-
forming growth factor beta (TGF-β), platelet-derived
growth factor (PDGF), insulin-like growth factor-1 (IGF-
1), and vascular endothelial growth factor (VEGF) that
have synergistic effects on cartilage matrix synthesis and
mitigate the effects of catabolic cytokines such as
interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-
α). PRP was also found to increase the cell viability of
chondrocytes, the migration and chondrogenic differen-
tiation of MSCs, increasing chondrocyte and mesenchy-
mal stem cell proliferation, proteoglycan deposition, and
type II collagen deposition. Different results have been
reported on the application of PRP in chondral lesions.
Not all studies concluded that PRP has a positive effect
on cartilage repair [31]. In the study by Vaisman et al.,
the use of intraarticular BMS or PRP as coadjuvants to
the microfracture technique for the treatment of acute
chondral lesions was not associated with a significant
improvement of hyaline cartilage regeneration [32]. This
conclusion was only valid for the dosage used in that
particular study (one intraarticular dose of 0.4 mg of
betamethasone). Perhaps the PRP concentration was not
sufficient to promote chondral healing. On the other
hand, results from most animal studies have identified
the potential utility of autologous platelets, both in isola-
tion and as an adjunct to surgical procedures, to restore
normal hyaline cartilage in articular injuries. The results
of these studies have shown that the platelet supernatant
stimulate chondrocyte proliferation and may form a
scaffold for chondrocytes. Chondrocytes stimulated with
PRP in vitro has been shown to increase synthesis ofion Cell viability Subchondral bone Calcified cartilage
–max) Median (min–max) Median (min–max) Median (min–max)
0.7143 (0–1) 1.4286 (1–2) 0.8571 (0–3)
2.1429 (1–3) 2.2857 (2–3) 2.1429 (0–3)
3.0000 (3–3) 3.0000 (3–3) 3.000 (3–3)
0.0010 0.0005 0.0207
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ated after PRP treatment, demonstrating similar histo-
logical and biomechanical characteristics to normal
hyaline cartilage [15–28, 32]. Milano et al. performed ex-
perimental studies on the effect of autologous PRP with
microfracture on chondral defects in a sheep model and
reported that treatment with PRP revealed an improve-
ment of cartilage stiffness and showed higher ICRS
scores [22, 23]. Similar positive results in chondral defect
reconstruction with autologous platelets were found in
the present study. An improvement in macroscopic ob-
servation was observed in groups that were treated with
ACP, and histological analysis further supported these
findings. In fact, within the criteria evaluated according
to the histological ICRS score, all criteria showed a sig-
nificant improvement with the use of ACP associated
with microfracture compared to the microfracture treat-
ment alone. ACP injection might effectively modify the
joint microenvironment in order to facilitate cartilage re-
generation. In the present study, in addition to the
intraarticular ACP application, we also investigated the
effectiveness of both ACP application into the defect
covered by the periosteum and intraarticular ACP ap-
plication. In Groups 2 and 3, hyaline-like cartilage was
observed in knee defects; however, hyaline-like cartil-
age was more abundant in Group 3. In the same
groups, all animals presented better chondral cellular-
ity and regeneration and lower fibrosis. Among all
groups, we observed the poorest healing in Group 1
and the best healing in Group 3. Furthermore, we
discovered that augmenting the defect using perios-
teum to cover the defect (as a scaffold) and subper-
iosteal and intraarticular ACP injection was superior
over microfracture application with respect to cartil-
age repair.
We believe that periosteum both contributes to joint
regeneration, and as a scaffold, it can maintain thrombo-
cyte concentration and growth factors for a longer time
within ACP, thus, providing an advantage in obtaining
a more hyaline-like cartilage and better results in
periosteum-administered groups. Moreover, we believe
that reporting different results after PRP application
results from the differences in the methods of obtain-
ing PRP, its concentration, method of activation, dose,
and method for applying PRP [1]. In the current study,
the preparation of PRP was performed according to
the protocol described by Borzini et al. [15]. In their
study, autologous PRP was used without performing a
platelet count, which constitutes evidence that PRP
can be prepared using this protocol.
This is a preliminary study, and hence, has certain lim-
itations. The current study included a histological evalu-
ation of the repair tissue for only up to 12 weeks after
surgery and on a limited number of animals as well asperiosteum that have many disadvantages that might not
have been obvious in this short-term follow-up. Increas-
ing the number of animals, and creating groups to in-
clude longer and different time periods, would increase
the strength of the study. We only evaluated morpho-
logical parameters and could not demonstrate the ef-
fectiveness of ACP at the molecular levels. The lack of
mechanical evaluation of the repair tissue is a short-
coming of this study. We did not analyze the plasma
thrombocyte levels in the present study. According to
the manufacturer’s reference, this procedure results in a
3-fold increase in thrombocyte count and a 2- to 6-fold
increase in growth factor levels (EGF, VEGF, TGF-β,
PDGF) [14, 28].
In conclusion, in the present study, we were able to
demonstrate a beneficial effect of intraarticular adminis-
tration of platelet-rich plasma as a coadjuvant of micro-
fractures in order to regenerate hyaline-like cartilage in
full-thickness chondral lesions in a rabbit model. Further
researches with well-designed randomized controlled tri-
als (RCTs) are required to validate the findings of this
study in clinical settings.
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